Assenagon Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $585K | Buy |
+31,403
| New | +$585K | ﹤0.01% | 988 |
|
|
2025
Q1 | – | Sell |
-98,231
| Closed | -$3.54M | – | 1310 |
|
|
2024
Q4 | $3.54M | Sell |
98,231
-279,334
| -74% | -$10.1M | 0.01% | 756 |
|
|
2024
Q3 | $16M | Buy |
377,565
+66,138
| +21% | +$2.8M | 0.03% | 385 |
|
|
2024
Q2 | $12.5M | Buy |
311,427
+85,000
| +38% | +$3.42M | 0.03% | 369 |
|
|
2024
Q1 | $8.02M | Buy |
+226,427
| New | +$8.02M | 0.02% | 463 |
|
|
2023
Q3 | – | Sell |
-12,053
| Closed | -$296K | – | 1424 |
|
|
2023
Q2 | $296K | Sell |
12,053
-26,372
| -69% | -$647K | ﹤0.01% | 1191 |
|
|
2023
Q1 | $1.56M | Sell |
38,425
-49,087
| -56% | -$1.99M | 0.01% | 906 |
|
|
2022
Q4 | $3.93M | Sell |
87,512
-202,703
| -70% | -$9.11M | 0.01% | 561 |
|
|
2022
Q3 | $13.9M | Sell |
290,215
-63,894
| -18% | -$3.06M | 0.05% | 267 |
|
|
2022
Q2 | $21M | Buy |
354,109
+234,135
| +195% | +$13.9M | 0.08% | 203 |
|
|
2022
Q1 | $14M | Buy |
119,974
+59,198
| +97% | +$6.88M | 0.04% | 270 |
|
|
2021
Q4 | $9.15M | Buy |
60,776
+16,140
| +36% | +$2.43M | 0.03% | 320 |
|
|
2021
Q3 | $5.33M | Sell |
44,636
-355,116
| -89% | -$42.4M | 0.02% | 382 |
|
|
2021
Q2 | $38.9M | Buy |
399,752
+195,481
| +96% | +$19M | 0.13% | 113 |
|
|
2021
Q1 | $18M | Buy |
204,271
+200,960
| +6,069% | +$17.7M | 0.07% | 202 |
|
|
2020
Q4 | $317K | Sell |
3,311
-9,661
| -74% | -$925K | ﹤0.01% | 863 |
|
|
2020
Q3 | $1.47M | Buy |
+12,972
| New | +$1.47M | 0.01% | 634 |
|
|
2020
Q1 | – | Sell |
-16,814
| Closed | -$1M | – | 948 |
|
|
2019
Q4 | $1M | Buy |
+16,814
| New | +$1M | 0.01% | 537 |
|